These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27597812)

  • 1. An analysis of patient-sharing physician networks and implantable cardioverter defibrillator therapy.
    Moen EL; Austin AM; Bynum JP; Skinner JS; O'Malley AJ
    Health Serv Outcomes Res Methodol; 2016 Sep; 16(3):132-153. PubMed ID: 27597812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing Variation in Implantable Cardioverter Defibrillator Therapy Guideline Adherence With Physician and Hospital Patient-sharing Networks.
    Moen EL; Bynum JP; Austin AM; Skinner JS; Chakraborti G; O'Malley AJ
    Med Care; 2018 Apr; 56(4):350-357. PubMed ID: 29419707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician network position and patient outcomes following implantable cardioverter defibrillator therapy.
    Moen EL; Bynum JP; Skinner JS; O'Malley AJ
    Health Serv Res; 2019 Aug; 54(4):880-889. PubMed ID: 30937894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician patient-sharing relationships and healthcare costs and utilization in China: social network analysis based on health insurance data.
    Hu H; Zhang Y; Zhu D; Guan X; Shi L
    Postgrad Med; 2021 Sep; 133(7):798-806. PubMed ID: 34139934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling peer effect modification by network strength: The diffusion of implantable cardioverter defibrillators in the US hospital network.
    O'Malley AJ; Moen EL; Bynum JPW; Austin AM; Skinner JS
    Stat Med; 2020 Apr; 39(8):1125-1144. PubMed ID: 31925971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing physician knowledge regarding indications for a primary prevention implantable defibrillator and potential barriers for referral.
    Bernier R; Raj SR; Tran D; Reyes L; Sauve M; Sumner GL; Exner DV; Sandhu RK
    J Cardiovasc Electrophysiol; 2017 Nov; 28(11):1334-1341. PubMed ID: 28841249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the US Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007-2015.
    Desai NR; Bourdillon PM; Parzynski CS; Brindis RG; Spatz ES; Masters C; Minges KE; Peterson P; Masoudi FA; Oetgen WJ; Buxton A; Zipes DP; Curtis JP
    JAMA; 2018 Jul; 320(1):63-71. PubMed ID: 29971398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a Novel Network-Based Linchpin Score to Characterize Accessibility to the Oncology Physician Workforce in the United States.
    Moen EL; Brooks GA; O'Malley AJ; Schaefer A; Carlos HA; Onega T
    JAMA Netw Open; 2022 Dec; 5(12):e2245995. PubMed ID: 36525275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region.
    Hoang A; Shen C; Zheng J; Taylor S; Groh WJ; Rosenman M; Buxton AE; Chen PS
    Heart Rhythm; 2014 May; 11(5):849-55. PubMed ID: 24566233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Referring physicians' discordance with the primary prevention implantable cardioverter-defibrillator guidelines: a national survey.
    Castellanos JM; Smith LM; Varosy PD; Dehlendorf C; Marcus GM
    Heart Rhythm; 2012 Jun; 9(6):874-81. PubMed ID: 22306794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low referral pattern for implantable defibrillator therapy in a tertiary hospital: referral physician survey and Monte Carlo simulation.
    Mohamad T; Jacob S; Kommuri NV; Modi S; Aravindhakshan R; Lieberman R
    Am J Ther; 2011 Sep; 18(5):350-4. PubMed ID: 20335787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in patient-sharing networks of physicians across the United States.
    Landon BE; Keating NL; Barnett ML; Onnela JP; Paul S; O'Malley AJ; Keegan T; Christakis NA
    JAMA; 2012 Jul; 308(3):265-73. PubMed ID: 22797644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
    Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
    Shah B; Hernandez AF; Liang L; Al-Khatib SM; Yancy CW; Fonarow GC; Peterson ED;
    J Am Coll Cardiol; 2009 Feb; 53(5):416-22. PubMed ID: 19179199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.
    Buxton M; Caine N; Chase D; Connelly D; Grace A; Jackson C; Parkes J; Sharples L
    Health Technol Assess; 2006 Aug; 10(27):iii-iv, ix-xi, 1-164. PubMed ID: 16904046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable Cardioverter Defibrillator mHealth App for Physician Referrals and eHealth Education: ICD-TEACH Pilot Study.
    Gandhi S; Morillo CA; Schwalm JD
    JMIR Cardio; 2018 Nov; 2(2):e10499. PubMed ID: 31758779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional variation in the use of implantable cardioverter-defibrillators for primary prevention: results from the National Cardiovascular Data Registry.
    Matlock DD; Peterson PN; Heidenreich PA; Lucas FL; Malenka DJ; Wang Y; Curtis JP; Kutner JS; Fisher ES; Masoudi FA
    Circ Cardiovasc Qual Outcomes; 2011 Jan; 4(1):114-21. PubMed ID: 21139094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographic variation in implantable cardioverter-defibrillator use and heart failure survival.
    Epstein AJ; Polsky D; Yang F; Yang L; Groeneveld PW
    Med Care; 2012 Jan; 50(1):10-7. PubMed ID: 22167063
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.